Kyle McCollom
@kyle
The US gov should pay Novo $175B for the Ozempic patent (~12.5x revenue), hold it defensively, and let co’s manufacture/sell it for cheap. Would have a significant impact on annual cost of obesity ($175B) over the next decade and be a positive ROI for the US. And it’d reward Novo for its research and risk.
6 replies
2 recasts
22 reactions
Kyle McCollom
@kyle
Doesn’t involve price controls, allows an open market to enter and drive the price down, incentivizes more pharma R&D, and would improve more than just healthcare costs in the US. Oh and it’d help the rest of the world too.
0 reply
0 recast
0 reaction
Shinada
@shinada
I think the world should go through personalized medicine. Ozempic ( semiglutide) is peptide. .maybe in future the researchs show that banning the receptor with this peptide cause another diseases.
0 reply
0 recast
0 reaction
Kim
@xeroog
So naive. Leave the communism for FB.
0 reply
0 recast
0 reaction
JestemZero
@jestemzero
I've been a proponent of federally funded rewards for immediate public medication. Kind of like SpaceX competitions. Not sure it'll actually work but not against trying it.
0 reply
0 recast
0 reaction
Mm4
@mm4
Lets wait for studies on long term effects of using ozempic for non diabetic people first.
0 reply
0 recast
0 reaction
Keanu Cage 🔵🎩🤘🏻
@keanucage
They certainly need to do something. As the population ages costs are only going to continue to skyrocket. Not to mention all of the COPD and lung cancer they will be hit with 20 years from now with the prevalence of vapes etc for the younger gen’s. A real healthcare spend problem and it’s honestly frightening
0 reply
0 recast
0 reaction
the cook
@thecookabc.eth
i'm danish so i'm a novo stan, but there's no real reason to do this. you could just fix your legislation. is the federal government gonna buy every patent for 12.5x revenue every time something new and good comes along? why not just make a sustainable that protects resource scarce citizens?
1 reply
0 recast
0 reaction
